Today: 9 April 2026
Meta stock jumps on $6 billion Corning AI cable deal as earnings loom

Meta stock jumps on $6 billion Corning AI cable deal as earnings loom

New York, Jan 27, 2026, 09:35 (EST) — Regular session.

  • Meta shares jumped roughly 2% early Tuesday following a Corning supply agreement linked to AI data centers
  • Wall Street is gearing up for updates on 2026 capital spending and expenses when Wednesday’s results hit.
  • The EU tightens compliance rules for WhatsApp “channels” as part of its Digital Services Act enforcement

Meta Platforms (META.O) jumped about 2% to $672.36 early Tuesday after the Facebook parent struck a deal to pay Corning up to $6 billion for fiber-optic cables that will support AI data centers. Corning plans to ramp up production at its Hickory, North Carolina plant, where Meta will be a key customer. CNBC reported the contract payments extend through 2030. “Together with Meta, we’re strengthening domestic supply chains,” said Corning CEO Wendell Weeks. Reuters

The deal arrives alongside Meta’s earnings on Wednesday, shifting the debate from ad demand to the hefty costs of chips, power, and infrastructure. The key question: can Meta keep dumping cash into AI and still grow profits fast enough to support its valuation?

Big Tech earnings this week will reveal if last year’s AI-fueled surge can withstand another wave of spending. Microsoft and Meta face pressure to prove their costly AI investments are paying off, Reuters reported. Analyst forecasts and options still signal solid revenue growth for Meta, though rising costs from hiring and infrastructure could weigh on profits. David Wagner, a Big Tech investor at Aptus Capital Advisors, cautioned that “the first-mover advantage doesn’t always win the marathon.” Reuters

Calls from analysts have grown louder ahead of the earnings release. On Monday, Rothschild & Co Redburn’s James Cordwell upgraded Meta to Buy, raising his price target to $900 from $740. He argued that the stock doesn’t fully capture Meta’s long-term earnings potential, even as CEO Mark Zuckerberg seems to be back in “founder mode” with AI investments. Cordwell noted, “the upside potential far outweighs any near-term risks.” Meanwhile, TipRanks data showed options traders are bracing for about a 6.8% move in either direction post-results. TipRanks

Traders see it clearly: as data centers ramp up for AI workloads, wiring and connectivity costs spike. Fiber links shuttle data between servers and chips, and when expansion speeds up, suppliers ride the momentum.

Still, the debate over spending refuses to fade. Investors demand a clearer link between Meta’s AI investments and its main ad revenue—specifically, whether improvements in targeting, recommendations, and automation will push ad prices up and sustain growth.

The downside risks are intensifying. European regulators have labeled WhatsApp’s “channels” feature a “very large platform” under the Digital Services Act. This means Meta must take extra measures to address illegal and harmful content, with a compliance deadline set for mid-May 2026. The move increases both costs and legal uncertainty, just as Meta is already pouring money into the business. Reuters

Rivalry is heating up over AI features linked to ads and search, as competitors rush to pack new tools into consumer apps and marketing platforms. Even if Meta reports a strong quarter, its stock could still falter if guidance signals another jump in spending.

Meta is set to release its fourth-quarter and full-year 2025 results after Wednesday’s closing bell, with a conference call scheduled for 4:30 p.m. ET. Investors will zero in on the company’s 2026 outlook for expenses and capital expenditures—particularly spending on data centers and equipment—and watch for early indications that AI investments are driving revenue growth rather than just pushing costs higher. investor.atmeta.com

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Micron stock jumps as $24 billion Singapore fab plan targets NAND demand tied to AI
Previous Story

Micron stock jumps as $24 billion Singapore fab plan targets NAND demand tied to AI

Cloudflare stock jumps on “Clawdbot” AI agent buzz as Wall Street digs into earnings
Next Story

Cloudflare stock jumps on “Clawdbot” AI agent buzz as Wall Street digs into earnings

Go toTop